In a major article for Drug Discovery World, Dan Williams discussed the opportunities for ASO-based therapiesDr Dan WilliamsApr 151 min readRead more about this rare opportunity for ASOs in Drug Discovery World
Drug Target Review features an insightful article by Dan Williams that explores the extraordinary achievements of AI in drug design
Technology Networks features a major interview with Dr Uwe Meya, SynaptixBio’s CMO, in which the issues around organising, funding, and conducting clinical trials for rare diseases are discussed.
Dan Williams contributes to a major article for Inside Precision Medicine, in which several US families with a child living with H-ABC discuss their journey to a diagnosis
